<DOC>
	<DOCNO>NCT00914888</DOCNO>
	<brief_summary>The main purpose study compare safety tigecycline versus ceftriaxone regimen pediatric subject ( age 8 17 year ) complicate intra-abdominal infection ( cIAI ) community acquire pneumonia ( CAP ) .</brief_summary>
	<brief_title>Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections &amp; Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Male female subject 8 17 year old . Children bone maturation le 8 year old enrolled caution due potential risk tooth discoloration . Have diagnosis serious infection ( complicate intraabdominal infection [ cIAI ] community acquire pneumonia [ CAP ] applicable ) require hospitalization administration IV antibiotic therapy . Criteria related indication ( cIAI CAP applicable ) , e.g. , sign systemic infection , sign symptom . Subject concomitant illness/condition , investigator 's judgment , substantially increase risk associate subject 's participation and/or completion study , could preclude evaluation subject 's response ( e.g. , life expectancy &lt; 30 day ) .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>child</keyword>
	<keyword>pediatry</keyword>
	<keyword>pneumonia</keyword>
	<keyword>intra-abdominal</keyword>
	<keyword>infection</keyword>
</DOC>